Cargando…
Leukotriene inhibitors with dexamethasone show promise in the prevention of death in COVID-19 patients with low oxygen saturations
INTRODUCTION: COVID-19 is a major health threat around the world causing hundreds of millions of infections and millions of deaths. There is a pressing global need for effective therapies. We hypothesized that leukotriene inhibitors (LTIs), that have been shown to lower IL6 and IL8 levels, may have...
Autores principales: | Elkin, Peter L., Resendez, Skyler, Mullin, Sarah, Troen, Bruce R., Mammen, Manoj J., Chang, Shirley, Franklin, Gillian, McCray, Wilmon, Brown, Steven H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274389/ https://www.ncbi.nlm.nih.gov/pubmed/35836784 http://dx.doi.org/10.1017/cts.2022.401 |
Ejemplares similares
-
COVID-19 vaccination and venous thromboembolism risk in older veterans
por: Elkin, Peter L., et al.
Publicado: (2023) -
58 Utilizing VA Data to Define Long COVID and Identify Patients at Risk
por: Elkin, Peter L., et al.
Publicado: (2023) -
Prevention of endogenous leukotriene production during anaphylaxis in the guinea pig by an inhibitor of leukotriene biosynthesis (MK-886) but not by dexamethasone
Publicado: (1989) -
Role of Leukotrienes and Leukotriene Modifiers in Asthma
por: Montuschi, Paolo
Publicado: (2010) -
Femoral venous oxygen saturation is no surrogate for central venous oxygen saturation
por: Van der Schors, A, et al.
Publicado: (2011)